TCL Archive In Brief: Byrd Heads ACS, Lee Clark President-Elect; NCI Needs Community Medical Oncologist November 7, 1975
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013